Literature DB >> 31422452

A miRNome analysis of drug-free manic psychotic bipolar patients versus healthy controls.

Silvia Tabano1, Alice Caldiroli2, Andrea Terrasi1,3, Patrizia Colapietro1, Silvia Grassi4, Greta Silvia Carnevali4, Laura Fontana1, Marta Serati4, Valentina Vaira1,3, A Carlo Altamura4, Monica Miozzo1,3, Massimiliano Buoli4.   

Abstract

The lifetime presence of psychotic symptoms is associated with more clinical severity, poorer outcome and biological changes in patients affected by bipolar disorder (BD). Epigenetic mechanisms have been evoked to explain the onset of psychotic symptoms in BD as well as the associated biological changes. The main objective of the present study was to evaluate the expression profiles of circulating microRNAs (miRNAs) in drug-free manic psychotic bipolar patients versus healthy controls (HC), to identify possible non-invasive molecular markers of the disorder. 15 drug-free manic psychotic bipolar patients and 9 HC were enrolled and 800 miRNAs expression profile was measured by Nanostring nCounter technology on plasma samples and validated through qPCR. Overall, twelve miRNAs showed a significantly altered expression between the two groups (p < 0.05). Functional annotation of predicted miRNAs targets by MultiMIR R tool showed repression in bipolar patients of genes with a role in neurodevelopment and neurogenesis, and upregulation of genes involved in metabolism regulation. We identified a signature of circulating miRNA characteristic of manic psychotic bipolar patients, suggesting a possible role in neurodevelopment and metabolic processes regulation.

Entities:  

Keywords:  Biomarkers; Bipolar disorder (BD); Epigenetics; Metabolism; Psychotic symptoms; miRNA

Mesh:

Substances:

Year:  2019        PMID: 31422452     DOI: 10.1007/s00406-019-01057-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  4 in total

Review 1.  miRNAs as potential diagnostic biomarkers and pharmacogenomic indicators in psychiatric disorders.

Authors:  Evangelia Eirini Tsermpini; Christina I Kalogirou; George C Kyriakopoulos; George P Patrinos; Constantinos Stathopoulos
Journal:  Pharmacogenomics J       Date:  2022-06-20       Impact factor: 3.245

2.  Predictors of fulvestrant long-term benefit in hormone receptor-positive/HER2 negative advanced breast cancer.

Authors:  Rosalba Torrisi; Valentina Vaira; Laura Giordano; Annarita Destro; Vera Basilico; Saveria Mazzara; Piermario Salvini; Gabriella Gaudioso; Bethania Fernandes; Noemi Rudini; Giovanna Masci; Armando Santoro
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

Review 3.  A Comprehensive Review on the Role of Non-Coding RNAs in the Pathophysiology of Bipolar Disorder.

Authors:  Soudeh Ghafouri-Fard; Elham Badrlou; Mohammad Taheri; Kenneth M Dürsteler; Annette Beatrix Brühl; Dena Sadeghi-Bahmani; Serge Brand
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

4.  Cataloging recent advances in epigenetic alterations in major mental disorders and autism.

Authors:  Hamid Mostafavi Abdolmaleky; Jin-Rong Zhou; Sam Thiagalingam
Journal:  Epigenomics       Date:  2021-07-28       Impact factor: 4.357

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.